baber/WOPTO huggingface dataset:
Patent NZ-537080-A (NZ)
Title: Remote interaction with a wireless device resident diagnostic interface across a wireless network
Inventor: CASSETT TIA M
IPC: H04B17/00
Filed: 2003-07-01
Abstract: A system (10) for remote interaction with a resident diagnostic interface (26) of a wireless device (12, 18, 20 and 22) comprises: a wireless network having at least data communication from computer devices selectively connected thereto and a plurality of wireless devices located remotely from each other and each in selective communication with other computer devices across the wireless network. Each wireless device includes a computer platform including a resident diagnostic interface for at least accessing status data comprised of device status data for the operating parameters of the wireless device, or both device status data and network status data, and the resident diagnostic interface is selectively accessible by other computer devices across the wireless network.
Patent NZ-537824-A (NZ)
Title: Cementitious material reinforced with chemically treated cellulose or non-cellulose fibers
Inventor: COOK JEFFREY TODD
IPC: D21C9/00
Filed: 2003-08-04
Abstract: A fiber-reinforced cement based material or cementitious material, and a process for making the same is disclosed, wherein the reinforcing fiber is a chemically treated cellulose fiber or a chemically treated non-cellulose fiber. The fiber reinforced cementitious material includes (a) cement, (b) optionally, sand, aggregate, or sand and aggregate, and (c) chemically treated fibers having a polyvalent cation content of from about 0.1 weight percent to about 5.0 weight percent based on the dry weight of the treated fibers, and having a weak acid content of from about 0.5 weight percent to about 10 weight percent based on the dry weight of the treated fibers.
Patent NZ-539041-A (NZ)
Title: Container for packaging perishable food items
Inventor: OWENSBY JOSEPH E
IPC: B65D81/20
Filed: 2005-03-24
Abstract: A container for packaging perishable food item, such as meat, particularly fresh red meat. The container comprising: a tubular body portion having two ends, said tubular body portion having a cross-section suitable for holding a perishable food item, wherein at least a portion of said tubular body is substantially transparent; one end of said body portion being closed and the other end of said body portion having an open mouth; and said open mouth is adapted to be sealed, wherein said tubular body portion has an arcuate top and a flat bottom having an undulating profile at each side forming a trough-like area.
Patent NZ-541294-A (NZ)
Title: Container having a detachable portion and a frangible tear line
Inventor: JACKSON ANDREW
Filed: 2005-07-18
Abstract: A container 70 erected from a blank 20 of foldable material comprises a pair of opposing side wall panels 22, 26, a respective opening 37, 46 in each side wall panel 22, 26, a detachable portion 60, and a frangible tear line extending along the container 70 such that the detachable portion 60 is able to be detached from the rest of the container 70 by tearing the container along the tear line. The tear line includes a respective pair of divergent segments 38, 39, 47, 48 extending from each opening 37, 46 and across each side wall panel 22, 26 to a respective edge or corner thereof.
Patent NZ-542503-A (NZ)
Title: Locking screw with crooked shank for medullary pin
Inventor: SCHLIENGER ANDRE
IPC: A61B17/72
Filed: 2003-03-28
Abstract: A locking screw, to be threaded into a transverse borehole of a medullary pin to hold the pin in bone, has a head 2 and a screw shaft with a core 3 and an external thread 7. A curve 4 passing through the centres of gravity of the orthogonal cross sections of the screw shaft from the head of the screw to the free end 6 is not straight and includes points of inflection. By a judicious relative sizing of the borehole diameter and the locking screw diameter, as the screw is screwed into the borehole an elastic deformation along the axis of the pin is forced upon the locking screw to produce an angularly stable locking of the medullary pin.
Patent NZ-543158-A (NZ)
Title: A space adaptable ultrasonic cleaning apparatus
Inventor: LEE WAH-TONG
IPC: B08B9/08
Filed: 2004-07-16
Abstract: Disclosed is an ultrasonic apparatus (10) and method of using ultrasonic technology to clean the internal surface of barrels (28). Transducers (12, 14, 16) are inserting through the restricted opening or bunghole (26) of the barrel (28). The apparatus (10) is then induced to produce ultrasonic cavitations that result in the cleaning of the internal surface of the barrel (28).
Patent NZ-545145-A (NZ)
Title: Pharmaceutical composition containing water soluble drug
Inventor: MULYE NIRMAL
IPC: A61K9/24
Filed: 2004-08-06
Abstract: Disclosed is s process for preparing a bead coated with a water soluble drug for incorporation into a pharmaceutical composition comprising: (a) preparing a supersaturated drug solution containing a desired amount of the water soluble drug and an aqueous solution, which supersaturated drug solution is completely saturated at a first temperature but which is supersaturated at a second temperature which is below the first temperature; and (b) coating an inert bead with the supersaturated drug solution, the supersaturated drug solution being maintained at or below the first temperature but at or above the second temperature, wherein the second temperature is less than the first temperature and the second temperature is the temperature at which the aqueous solution containing the water soluble drug is supersaturated.
Patent NZ-548126-A (NZ)
Title: A process for the purification of antibodies involving addition of a second resin
Inventor: GRONBERG ANNA
IPC: B01D15/08
Filed: 2005-02-25
Abstract: Disclosed is a process for the purification of antibodies from one or more impurities in a liquid, which process comprises contacting said liquid with a first chromatography resin comprised of a support to which multi-modal ligands have been immobilised to adsorb the antibodies to the resin, wherein each multi-modal ligand comprises at least one cation-exchanging group and at least one aromatic or heteroaromatic ring system; adding an eluent to release the antibodies from the resin; and contacting the eluate so obtained with a second chromatography resin. In one embodiment, the ring-forming atoms of the aromatic or heteroaromatic entity are selected from the group consisting of C, S and O, and the cation exchanging group is a weak cation exchanger.
Patent NZ-548612-A (NZ)
Title: Albumin fusion proteins comprising tandem GLP-1
Inventor: ROSEN CRAIG A
IPC: C07K14/76
Filed: 2005-02-09
Abstract: Disclosed is an albumin fusion protein comprising two or more tandemly oriented Glucagon-Like-Peptide 1 (GLP-1) polypeptides, wherein said GLP-1 polypeptides are selected from wild-type GLP-1, functional fragments and functional variants thereof, fused to albumin or a functional fragment or functional variant thereof, wherein said albumin fragment or variant increases the serum plasma half-life of unfused GLP-1 polypeptides, and wherein said fusion protein has GLP-1 activity, and wherein the albumin fusion protein further comprises a leader sequence.
Patent NZ-551422-A (NZ)
Title: Piping bag with non-slip surface, blank for manufacturing a piping bag and method of manufacturing a piping bag
Inventor: EJEBLAD ALLAN
IPC: A23G3/34
Filed: 2005-02-04
Abstract: Disclosed is a disposable piping bag (1), comprising a container of polymer film. The piping bag is made essentially from a thin walled polymer tube. An outwardly oriented surface of the piping bag is provided with a rough surface structure. The outwardly orientated surface of the polymer tube comprises friction enhancing agents.
Patent NZ-556600-A (NZ)
Title: Solid mixed metal compounds as pharmaceutically active phosphate binders, their manufacture, compositions containing them and their use
Inventor: NEWTON MAURICE SYDNEY
IPC: A61K33/24
Filed: 2006-02-09
Abstract: Disclosed is a solid mixed metal compound of formula MII1-aFe3+aObAn-c.zH2O, wherein MII is at least one bivalent metal, An- is at least one n-valent anion, 2+a=2b+Sigma cn and Sigma cn<0.9a. Also disclosed is a solid mixed metal compound obtained by heating a starting material comprising a layered double hydroxide structure at a temperature of 250-500 degrees C. Also disclosed is the use of a compound described above for binding phosphate, and in the treatment of hyperphosphataemia. Also disclosed is a method of making the above compounds, and pharmaceutical compositions containing them.
Patent NZ-567202-A (NZ)
Title: Silk proteins from Hyhemonptera species containing heptad repeats that form coiled coil tertiary structures
Inventor: SUTHERLAND TARA D
IPC: C07K14/435
Filed: 2006-10-04
Abstract: Disclosed is a substantially purified and/or recombinant silk polypeptide, wherein at least a portion of the polypeptide has a coiled coil structure, and wherein the polypeptide comprises a sequence selected from: i) an amino acid sequence as provided in any one of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:40, SEQ ID NO:41, SEQ ID NO:56, SEQ ID NO:57; SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:42, SEQ ID NO:43, SEQ ID NO:58, SEQ ID NO:59, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:44, SEQ ID NO:45, SEQ ID NO:60, SEQ ID NO:61, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:28, SEQ ID NO:29, SEQ ID NO:46, SEQ ID NO:47, SEQ ID NO:62, SEQ ID NO:63, SEQ ID NO:72 or SEQ ID NO:73; ii) an amino acid sequence which is at least 70% identical to any one of the sequences of i); and iii) a biologically active fragment of i) or ii).
Patent NZ-574097-A (NZ)
Title: Cgrp receptor antagonists
Inventor: GUTIERREZ COREY
IPC: A61K31/4468
Filed: 2007-06-13
Abstract: Disclosed is a thiazolidine compound of formula (I) where the substituents are as disclosed in the specification. Example of compound of formula (I) include: 1-(1-(2-(4-Oxo-2-phenyl-3-((pyridin-4-yl)methyl)thiazolidin-5-yl)acetyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one; 3,4-Dihydro-3-(1-(2-(3-methyl-4-oxo-2-phenylthiazolidin-5-yl)acetyl)piperidin-4-yl)quinazolin-2(1H)-one and 3-(1-(2-(3-Isopentyl-4-oxo-2-phenylthiazolidin-5-yl)propanoyl)piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one. Also disclosed is the pharmaceutical composition comprising a compound of formula (I) and the use of a compound of formula9I) in the manufacture of a medicament for treating or preventing headache; migraine; cluster headache; chronic tension type headache; pain; chronic pain; neurogenic inflammation and inflammatory pain; neuropathic pain; eye pain; tooth pain; diabetes; non-insulin dependent diabetes mellitus; vascular disorders; inflammation; arthritis; bronchial hyperactivity, asthma; shock; sepsis; opiate withdrawal syndrome; morphine tolerance; hot flashes in men and women; allergic dermatitis; encephalitis; brain trauma; epilepsy; neurodegenerative diseases; skin diseases; neurogenic cutaneous redness, skin rosaceous and erythema; tinnitus; inflammatory bowel disease, irritable bowel syndrome, or cystitis.
Patent NZ-574312-A (NZ)
Title: Novel pyridazine compound and use thereof
Inventor: BONDY STEVEN S
IPC: C07D403/14
Filed: 2007-07-06
Abstract: Disclosed is 5-({ 6-[2,4-bis(trifluoromethyl)phenyl]pyridazin-3-yl} methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine of the formula (1) and processes for its preparation. Intermediates of formula (3), including those which are substituted with methyl rather than chloromethyl, and its analogues substituted with bromo, fluro or iodo in place of chloro are also disclosed. Compound (1) is useful for therapy or prophylaxis of HCV infections.
Patent NZ-574389-A (NZ)
Title: Antiviral use of cationic surfactant
Inventor: ROCABAYERA BONVILA XAVIER
IPC: A61K31/16
Filed: 2006-08-03
Abstract: Disclosed is a cationic surfactant of formula 2 which is derived from the condensation of fatty acids and esterified dibasic amino acids for the manufacture of a medicament for the treatment of virus infections in animals or human beings. The variables are as disclosed in the description. Also disclosed in the use of the cationic surfactant for treating products that may be affected by virus contamination and the method of treating a non-human animal for a virus infection using a cationic surfactant of formula 2.
Patent NZ-574443-A (NZ)
Title: Short duration depot formulations
Inventor: CHEN GUOHUA
IPC: A61K47/32
Filed: 2003-06-25
Abstract: Disclosed is a sustained release dosage form of an anesthetic, said dosage form comprising: a short duration gel vehicle comprising a low molecular weight bioerodible, biocomparible polymer and a water-immiscible solvent in an amount effective to plasticise the polymer and form a gel therewith; and an anesthetic dissolved or dispersed in the gel vehicle , wherein said polymer is a lactic acid-based polymer having a weight from about 3,000 to about 10,000, said solvent is benzyl alcohol, and said anesthetic is bupivacaine, and further wherein the dosage form provides for a reduced initial burst of the anesthetic from the dosage form after local administration. (62) Divided Out of 537313
Patent NZ-578959-A (NZ)
Title: Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf)
Inventor: HOCHREIN HUBERTUS
IPC: C12N5/0789
Filed: 2008-04-25
Abstract: Disclosed is an in vitro method for generating dendritic cells (DCs) in the presence of Macrophage-Colony Stimulating Factor (M-CSF) without the co-administration of a further growth factor known to induce DCs generation comprising (i) culturing a hematopoietic precursor cell; and (ii) administering M-CSF. Further disclosed is a recombinant poxvirus comprising a nucleic acid sequence coding for M-CSF.
Patent NZ-579268-A (NZ)
Title: Method for improving the bud quality of a plant
Inventor: ROSATI DOMINIQUE
IPC: A01N59/26
Filed: 2008-05-16
Abstract: Provided is a method for improving the quality of the buds of a perennial plant, the method comprising applying a compound chosen from phosphorous acid and fosetyl-Al to the plant during the period of initiation of the flower buds in the post-flower period. The compound increases the number of flower buds in the flower due to less die-back and better development of the buds.
Patent NZ-579848-A (NZ)
Title: Acidified dairy food comprising non-alkalised cocoa shells
Inventor: BRANDSTETTER BERNHARD
IPC: A23G1/00
Filed: 2009-09-22
Abstract: Disclosed is an acidified dairy food comprising cocoa shells. The disclosed dairy food is selected from a cheese, sour cream, buttermilk, kefir, or fromage frais, and the cocoa shells are non-alkalised.
Patent NZ-585508-A (NZ)
Title: Device for counteracting an unintended turning force on a vessel caused by the propeller torque
Inventor: SMITH THOMAS KENWORTHY
IPC: A01K97/00
Filed: 2010-06-25
Abstract: A course correction system (100) suitable for a lightweight watercraft or "Kontiki" type fishing equipment is disclosed. This type of craft has a propeller (160) that is disposed below the hull of the vessel. During movement thought the water this causes the vessel to list due to the rotational force of the propeller, offsetting the axis of rotation of the propeller (160) from directly beneath the hull and causing the vessel to deviate from a straight course. To counter this effect a counter-force imparting body (230) is placed behind the propeller along the propulsion axis. The body has two correcting surfaces (250, 260), angled opposite to each other, each having a negative pitch angle with respect to the mean pitch of the driving surface (200, 210, 220) of each of the propellers blades (170, 180, 190). This creates a force-couple which rights the vessel, preventing the rotation and thus stabilising the course.
Patent NZ-588999-A (NZ)
Title: Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
Inventor: BECQUERELLE SOPHIE
IPC: A61K38/43
Filed: 2009-05-07
Abstract: Disclsoed are compositions provided for inhibiting the growth of susceptible microorganisms by contacting the microorganisms, in the presence of a peroxide and chloride or bromide, with myeloperoxidase and at least two activity-enhancing agent amino acids.
Patent NZ-592389-A (NZ)
Title: Scissors and sharpening arrangement with pair of positioning units and pair of sharpening units within sharpening housing
Inventor: MURPHY ROSEMARY
IPC: B24D15/06
Filed: 2009-10-15
Abstract: 592389 The disclosure relates to scissors and a sharpening device. The scissors include two blades, each blade having a cutting edge and a back edge which respectively form opposite longitudinal edges of the blade. A pivot connects the two blades for relative movement of the blades between an open condition in which the cutting edge of each blade are apart and a closed condition in which each blade are substantially adjacent and the back edge of each blade projects beyond the cutting edge of the other blade. The blades also include a sharpening condition in which the cutting edge of each of the blades can be sharpened. A biasing means is included for biasing the blades away from the sharpening condition towards the closed condition and/or the open condition. The sharpening device is for scissors including two blades having a cutting edge. The sharpening device includes a hollow housing for receiving the blades of the scissors, a pair of positioning units within the housing arranged in an opposed relationship to receive the blades therebetween when the scissors are inserted into the housing, and a pair of sharpener units located within the housing arranged in an opposed relationship to contact the blades therebetween.
Patent NZ-595113-A (NZ)
Title: Rosuvastatin and atorvastatin derivatives
Inventor: LINDSAY DEREK
IPC: A61P9/00
Filed: 2010-03-10
Abstract: 595113 Disclosed herein is a compound of Formula I, wherein A is defined in the specification; R1a is i-propyl, R2a is -S(O)2Me, R3a is methyl and R4a 4-fluorophenyl; R5 and R6 are independently selected from the group comprising: hydrogen, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl, C3-6 cycloalkyl, aryl, C1-6 alkyl aryl, C1-6 alkanoyl aryl, heteroaryl, C1-6 alkanoyl heteroaryl and C1-6 alkyl heteroaryl; provided always that both R5 and R6 are not hydrogen; and provided that R5 is not benzyl or H when R6 is methyl. R7 and R8 are independently selected from the group comprising: H, C1-4 alkyl and halo; X is -(CRaRb)m(CRa=CRb)n(CRaRb)o- where Ra and Rb are independently selected from the group comprising: H, methyl, ethyl and halo and m, n, and 0 are independently 0, 1, 2, or 3 provided that m + n + 0 is not more than 3; and wherein each of the above R groups may, where chemically possible, be independently optionally substituted by from 1 to 5 groups chosen independently at each occurrence from the groups comprising: halo, C1-3 alkyl, halo C1-3 alkyl, C1-3 alkoxy, C1-3 haloalkoxy, hydroxy, and cyano.
Patent NZ-595151-A (NZ)
Title: Modulators of cystic fibrosis transmembrane conductance regulator
Inventor: ZLOKARNIK GREGOR
IPC: A61K31/47
Filed: 2010-03-19
Abstract: ABSTRACT - 595151 Disclosed is a compound of formula (I) which are modulators of cystic fibrosis transmembrane conductance regulator ("CFTR"), wherein R is COOH or CH2OH. These compounds are particularly suitable for treating disease selected from cystic fibrosis, smoke induced COPD, pancreatitis, pancreatic insufficiency, hereditary emphysema, COPD, and dry-eye disease.
Patent NZ-596323-A (NZ)
Title: Back-up or fail-safe monitoring, data recording, temperature control system for refrigerators or chilled spaces or apparatus for storing biological material such as vaccines
Inventor: RYALL JOHN HANSEN
IPC: F25B49/00
Filed: 2012-05-07
Abstract: Disclosed are control means for a refrigerator for maintaining internally stored biological materials within known upper and lower temperature storage limits. The refrigerator includes a heat pump driven by a supply of electricity in series with a first thermally sensitive electric power switch capable of closing and thereby applying power to the heat pump if the temperature rises above a first predetermined temperature or of opening and disconnecting the power if the temperature falls below the first predetermined temperature. The first power switch is placed electrically in series with a second thermally sensitive electric power switch, also responsive to the temperature of the storage space by closing if the temperature rises above a second predetermined temperature or opening if the temperature falls below a second predetermined temperature. The second predetermined temperature is less than the first predetermined temperature so that the contacts of the second electric power switch are conserved yet can act to protecting the biological materials from undue cold if the first switch should become always closed.
Patent NZ-598132-A (NZ)
Title: Gas barrier heat-shrinkable film
Inventor: URSINO FELICE
IPC: B32B27/08
Filed: 2010-09-14
Abstract: 598132 A coextruded annealed gas-barrier heat-shrinkable packaging film suitable for flowpack or tray-lidding applications comprises a core EVOH layer (A), first and second outer polyolefin layers (B) and (C), and at least one inner layer (D) of a copolymer of propylene with butane and optionally also with ethylene, and is characterized by a maximum shrink force in the transverse direction ≤ 0.35 N/cm and may also be characterized by a residual shrink force in the range 0.08 to 0.30 N/cm. The film is obtained by coextrusion, optional irradiation, and orientation and annealing at a temperature of from 70 to 90 °C.
Patent NZ-600474-A (NZ)
Title: Synthesis process, and crystalline form of 4-{ 3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy} benzamide hydrochloride and pharmaceutical compositions containing it
Inventor: ROBERT NICOLAS
IPC: A61P25/00
Filed: 2012-06-06
Abstract: Process for the industrial synthesis of the compound of formula (I) (4-{ 3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy} benzamide hydrochloride) characterised in that the compound of formula (II) is reacted with ammonia at a temperature greater than 100 degrees C to form the compound of formula (III) which is reduced to yield the bicyclic amine of formula (IV) which latter compound is subsequently subjected to - either to a coupling reaction, under basic conditions in a polar medium, with a compound of formula (V) wherein the substituents are as disclosed in the specification, - or to reductive amination, in an acid medium, with a compound of formula (V') wherein the substituents are as disclosed in the specification, - or to reductive amination with the compound of formula (V") to yield the free base of the compound of formula (I), which is placed in the presence of HCl (hydrochloric acid) to form the compound of formula (I), which is isolated in the form of a solid. Also disclosed are the compounds of formula (V) and (V') in particular 4-(3,3-diethoxypropoxy)benzamide; the use of compounds of formulae (V), (V') and (V'') for preparing a compound of formula (I); crystalline form I of a compound of formula (I) characterised by x-ray powder diffraction spectra, Raman spectra and solid state NMR spectra. Further disclosed is the use of a compound of formula (I) for the manufacture of a medicament for the treatment of the histaminergic system; the treatment of cognitive and psycho-behavioural disorders associated with cerebral ageing and with neurodegenerative diseases, and also for the treatment of mood disorders, attention-deficit hyperactivity syndrome, obesity and pain; the treatment of cognitive and psycho-behavioural disorders associated with Alzheimer's disease, Parkinson's disease, Pick's disease, Korsakoff's disease, Lewy body dementias, frontal and subcortical dementias, frontotemporal dementias and vascular dementias.